AA
ARNA

Ancora Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Ancora Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-40
Closed -$1K – 1143
2016
Q4 		$1K Buy
+40
New +$620 ﹤0.01% 1217
2015
Q1 		– Sell
-1,500
Closed -$52K – 522
2014
Q4 		$52K Buy
+1,500
New +$60.9K 0.01% 482

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ancora Advisors's ARNA Position: Q1 2017 in Review

Ancora Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2017, closing a stake of 40 shares — an estimated $1K sold.

Ancora Advisors first reported a position in ARNA in Q4 2014 and held it in 2 quarters. The position peaked at $52K in Q4 2014. 126 funds tracked by Wall St. Rank hold ARNA as of Q1 2017.

  • Ancora Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Ancora Advisors sold 40 Arena Pharmaceuticals Inc shares in Q1 2017, an estimated $1K.
  • Ancora Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2014 and held it in 2 quarters.
  • Ancora Advisors's Arena Pharmaceuticals Inc position peaked at $52K in Q4 2014.
  • 126 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2017.

Based on Ancora Advisors's 13F filing for Q1 2017, filed 15 May 2017.